HC Wainwright & Co. Reiterates Buy on Humacyte, Maintains $3 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.4%

Neg 0% Neu 89.4% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Humacyte (NASDAQ:HUMA) with a Buy and maintains $3 price target.